Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib
2021-04-01 14:09
Gracell Biotechnologies Signs Agreement with Lonza to Manufacture Gracell's FasTCAR Product Candidates in the U.S.
2021-03-31 20:45
VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper
2021-03-31 20:30
Gracell Biotechnologies Announces Enrollment of First Patient in Registrational Phase 1/2 Clinical Study for GC007g, an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL
2021-03-31 20:00
AffaMed Therapeutics and SIFI Announce Joint Venture to Serve Greater China Market
2021-03-31 19:30
3SBio announces 2020 annual results, tapping integrated platform advantages for steady growth
2021-03-31 09:11
ImmuneOncia and 3D Medicines Signed Exclusive License Agreement to Develop, Manufacture and Commercialize IMC-002 in Greater China
2021-03-31 09:00
VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary
2021-03-30 20:30
AffaMed Therapeutics Announces Completion of over US$170 Million Series B Financing Led by Lake Bleu Capital to Further Development of Ophthalmic and Neuroscience Pipeline
2021-03-30 19:30
Instylla Announces Enrollment of Initial Patients in the Embrace™ Hydrogel Embolic System Global Randomized Multi-Center Clinical Trial
2021-03-30 19:02
TurtleTree Scientific and JSBiosciences enter into a strategic partnership for the development of cell culture media and contract manufacturing services
2021-03-30 06:00
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
2021-03-30 04:30
VolitionRx Limited Appoints Two New Directors
2021-03-30 04:10
Fosun Pharma Announces 2020 Annual Results
2021-03-30 00:38
HOYA Confirm the Long Term Technical Collaboration and Supply Agreement Related to Endoscopic Ultrasound Systems
2021-03-29 22:00
Tigermed Reports 2020 Annual Results With Solid Growth
2021-03-29 21:21
Jacobio Pharma Announces CNY486 Million Revenue for 2020 Annual Results
2021-03-29 13:11
Foresee Pharmaceuticals Announces Dosing of First Patient in Phase 2/3 Clinical Trial of FP-025 for Treatment of COVID-19 Associated ARDS
2021-03-28 11:04
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results
2021-03-27 05:00
Kintor Pharmaceutical Limited Announces 2020 Business Progress and Annual Results
2021-03-26 20:54
1
292
293
294
295
296
871